An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of Choline

Not Applicable

Completed

• Conditions: Healthy
• Interventions: Dietary Supplement: non-probiotic control; Dietary Supplement: probiotics intervention

• Registration Number: NCT03292978
• Lead Sponsor: Huilian Zhu

Brief Summary

The aim of the study is to examine the effects of probiotics intervention on choline metabolites and intestinal microbiota composition using a randomized double blind clinical trial. Also, we proposed to explore the real-time change of choline metabolites after probiotics intervention through a PC challenge test. Our study will clarify the biochemical pathway involved in metabolic diseases and hope to provide a new targeted-preventive and therapeutic strategy for chronic metabolic diseases.

Detailed Description

Dietary choline (mainly refer to phosphatidylcholine, PC) produce trimethylamine (TMA) through the action of gut flora in vivo. TMA then readily absorbed into systemic circulation and oxidized by hepatic flavin monoxygenases (FMO3) to trimethylamine-N-oxide (TMAO). The elevated levels of circulating TMAO is identified as a risk factor for the prevalence and development of metabolic diseases such as cardiovascular diseases and nonalcoholic fatty liver diseases. Targeting gut flora for reducing TMAO may be a promising approach for preventing chronic metabolic diseases. Recent studies found that some strains representing two different phyla (Firmicutes and Proteobacteria) are capable of producing TMA from choline in vitro. On the other hand, TMA intervention can change the structure of intestinal flora, reducing the abundance of bifidobacterium and lactobacillus. Probiotics can improve the ecological balance of the gut flora, which might be beneficial to human health and disease prevention. However, whether probiotics could inhibit the TMA-producing bacterias and reduce the TMA and TMAO levels through balancing the gut flora was unclear.

In order to explore whether probiotics can reduce the TMA and TMAO levels, we are proposed to recruit 50 volunteers aged from 18-30 years old to participate in the randomized double-blind trial. The volunteers are randomized allocated into different intervention groups. The probiotics intervention group is provided once daily orally-taken powder in a sachet, which contains 4 strains of probiotics. The non-probiotic control is provided with a powder without probiotics , but has same look, color, taste, flavor and weight as the probiotics intervention group. A PC challenge test will be hold before and after the 4 weeks intervention. The blood and fecal sample will be collected before and after the trial and analyzed by appropriate method. The dietary assessment is assessed by a 3-day dietary record.The statistic analysis is by SPSS 23.0.

Study Timeline

• Study Start: 2017-07-01
• Study First Submitted: 2017-09-19
• Study First Submitted QC: 2017-09-22
• Study First Posted: 2017-09-26
• Primary Completion: 2017-12-31
• Study Completion: 2018-12-31
• Status Verified: 2019-11
• Last Update Submitted: 2019-11-11
• Last Update Posted: 2019-11-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

• Healthy males at 18 to 30 years old;
• Free from antibiotics and probiotic products for at least 1 month;
• Willing to participate in the study, consume the test product and perform all measurements.

Exclusion Criteria

• Sever physical diseases;
• Intolerance to probiotics or eggs

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
non-probiotic control	non-probiotic control	The placebo is corn starch alone provided and the shape, color, weight,flavor and taste are same with the powder of probiotics intervention.
probiotics intervention	probiotics intervention	1. The probiotic is provided in sachets as a 2g powder dried with corn starch. 2. The powder is orally taken once daily for 4 weeks. 3. The powder contains totally 11 log 10 colony forming units(CFU) of probiotics. 4. The types of probiotics are Lactobacillus.rhamnosus, Lactobacillus.acidophilus, Bifidobacteria.animalis and Bifidobacteria.longum.

Primary Outcome Measures

Name	Time	Method
choline metabolites	4 weeks later	The metabolites of choline before and after the intervention including free choline, betaine, TMA, TMAO will be measured by UPLC/MS.

Secondary Outcome Measures

Name	Time	Method
intestinal microbiota composition	4 weeks later	The intestinal microbiota composition of feces before and after the intervention will be examined by 16S-DNA.
anthropometry measurement	4 weeks later	The height and weight which are combined to report BMI in kg/m\^2 will be measured before and after the intervention by professional investigators.
blood biochemical markers	4 weeks later	Overnight fasting serum total cholesterol (TC), triglyceride (TG), LDL cholesterol (LDLc), HDL cholesterol (HDLc) and fasting blood glucose were measured by colorimetric methods using a Hitachi 7600-010 automated analyzer.

Trial Locations

Locations (1)

SunYat-sen University; 🇨🇳 Guangzhou, Guangdong, China